The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Data sample demographics. Note that AP refers to anti-psychotic medication, and AD refers to anti-depressive medication. Thus, AP and AD in this table refer to the percentage of pa... by Eloy Geenjaar (21533195)

Linear regression analysis results for the effect of log-transformed urinary BPA concentrations at two time points on serum thyroid concentrations at ages 10–12. by Jung Eun Choi (563339)

Subjects:

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Results of weighted arcsine-transformed linear regression of the age-and sex-standardised epilepsy prevalence (y) and age- and sex-standardised anti-Ov16 seroprevalence (x<sub>1</s... by Luís-Jorge Amaral (16406704)

Subjects:

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Table 1_NSAID use may decrease serum Klotho levels.docx by Jingchao Yan (14079168)

“…Subgroup analyses did not reveal any statistically significant interactions.</p>Conclusion<p>Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.…”

Summary of person-years, deaths, median age at death, crude mortality rates, age- and sex-standardised mortality rates (per 1,000 person-years), and standardised mortality ratios (... by Luís-Jorge Amaral (16406704)

Subjects:

ZIP file containing the 3 datasets used during analysis: 1) Epilepsy suspected and mortality data; 2) Epilepsy confirmed data; 3) anti-Ov16 seroprevalence data per study site. by Luís-Jorge Amaral (16406704)

Subjects:

Relationship between age- and sex-standardised anti-Ov16 seroprevalence in children aged 3‒9 years and age- and sex-standardised confirmed prevalence of epilepsy (A) and probable n... by Luís-Jorge Amaral (16406704)

Subjects:

Location of (A) South Sudan and (B) study counties (Maridi, Mundri East, Mundri West, Mvolo and Wulu). by Luís-Jorge Amaral (16406704)

Subjects:

Classification of study villages according to their distance from rivers with confirmed vector (<i>Simulium damnosum</i> sensu lato) breeding grounds for the five South Sudanese st... by Luís-Jorge Amaral (16406704)

Subjects:

Epilepsy, including probable nodding syndrome (pNS), and pNS prevalence per study county in high- and low-risk sites in South Sudan. by Luís-Jorge Amaral (16406704)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

“…The substantial and differential decrease in testosterone and SHBG levels does not explain our previous finding of no detected decrease in risky sexual behavior or sexual function for DMPA-IM or NET-EN users from D0 to 25W. …”

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

“…The analysis found a significant association across all subjects for Shannon diversity with decreasing diversity in the lead up to the next treatment (lmer model, beta = -0.018, <i>p</i> = 0.036) and no association for observed diversity (<i>p</i>>0.1). …”